Moreover, this accords with FADS2 being a risk locus for CRC [54] and the ability of aspirin to irreversibly inhibit COX-1 and COX-2 and lower proinflammatory signals for CRC chemoprevention [55]. This evidence concerns the gene FADS2 and colorectal carcinoma.